STAT3 and neoplasm: IL-6, activating the JAK/STAT3 pathway, stimulates inflammatory processes in the tumor microenvironment, which paradoxically support tumor development, promote angiogenesis, and support the adaptation of tumor cells to therapy, including chemotherapy [49,50,51,52,53].